O-6-Benzylguanine (BG): Began Phase II trial

Procept Inc., Cambridge, Mass. Product: O-6-Benzylguanine (BG) Business: Cancer Therapeutic category: Adjunct Target: AGT in tumor cells Description: Chemosensitizing agent that inhibits the O-6 alkyl...